Concepedia

Author

Flavio Arienti

Fondazione IRCCS Istituto Nazionale dei TumoriORCID

Also Known As

Arienti Flavio, F ARIENTI, F Arienti, F. Arienti, F. arienti, Flavio Arienti

137

Publications

4.8K

Citations

34

H-Index

63

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei TumoriUniversity of Milano-BicoccaUniversity of MilanCentro di Riferimento OncologicoUCLouvain
FA

About

Flavio Arienti is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

25

2.3K

2

Health Sciences

2

2

114

3

Engineering

1

1

19

4

Social Sciences

1

1

62

5

Biomedical Engineering

1

1

19

Flavio Arienti

×

54

Publications

4.3K

Citations

32

H-Index

YearCitations

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

Marie Marchand, Nicolas van Baren, P. Weynants,

International Journal of Cancer

1999

786

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

Filiberto Belli, Alessandro Testori, Licia Rivoltini,

Journal of Clinical Oncology

2002

385

Expression of <i>MAGE</i> genes in primary and metastatic cutaneous melanoma

Francis Brasseur, Donata Rimoldi, Danielle Líénard,

International Journal of Cancer

1995

285

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma

Veronica Huber, Viviana Vallacchi, Viktor Fleming,

Journal of Clinical Investigation

2018

245

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

Daniel J. Hicklin, Z Wang, Flavio Arienti,

Journal of Clinical Investigation

1998

197

Regression of Advanced Ovarian Carcinoma by Intraperitoneal Treatment With Autologous TLymphocytes Retargeted by a Bispecific Monoclonal Antibody

Silvana Canevari, Gerrit Stoter, Flavio Arienti,

JNCI Journal of the National Cancer Institute

1995

191

Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cells

Carlo Gambacorti‐Passerini, F Grignani, Flavio Arienti,

Blood

1993

139

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

Lorenzo Pilla, Roberto Patuzzo, Licia Rivoltini,

Cancer Immunology Immunotherapy

2005

137

Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-α Results in the Activation of Specific CD8+ T Cells and Monocyte/Dendritic Cell Precursors

Tiziana Di Pucchio, Lorenzo Pilla, Imerio Capone,

Cancer Research

2006

115

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

Elisabetta Vergani, Lorenza Di Guardo, Matteo Dugo,

Oncotarget

2015

102

Page 1